Qinhong Xu

Qinhong Xu

Auto-generated profile, based on publicly available information

Qinhong Xu

Department of Hematology, Zhongshan Hospital, Xiamen University, Fujian Medical University Clinic Teaching Hospital, Xiamen, Fujian, China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2009 in Transplantation Proceedings
Verified
Journal Article
Closed access
YQyue qiu
yue qiu
XZX. Zhu
X. Zhu
WWW. Wang
W. Wang
QXQ. Xu
Q. Xu
YDY. Ding
Y. Ding

24 November 2021 in Medicine
Verified
Journal Article
Open access
QXQinhong Xu
Qinhong Xu
JYJieni Yu
Jieni Yu
XLXiaoyan Lin
Xiaoyan Lin
YLYouli Li
Youli Li
KZKejie Zhang
Kejie Zhang
Rationale: Monoclonal gammopathy of undetermined significance (MGUS) is a clinically asymptomatic clonal plasma cell or lymphoplasmacytic proliferative disorder. Recently, some case reports have described the association of pure red cell aplasia (PRCA) with MGUS, even with a relatively low monoclonal immunoglobulin burden. T large granular lymphocyte leukemia (T-LGLL) is a chronic lymphoproliferative disorder characterized by clonal expansion of T large granular lymphocytes, which is rare in China. There are some reports about T-LGL leukemia in patients with B-cell lymphoma; however, it is very rare that T-LGLL coexists with MGUS and clonal B-cell lymphoproliferative disorders (CB-LPD). Patient concerns: A 77-year-old man was hospitalized because of anemia. He was diagnosed with MGUS, CB-LPD, and PRCA. During the development of the disease, a group of abnormal T lymphocytes was detected by flow cytometry of peripheral blood. Diagnosis: Combining clinical manifestations with the result of T cell receptor gene rearrangement and immunophenotype, it was consistent with the diagnosis of T large granular lymphocyte leukemia. Interventions: The patient was treat with bortezomib and dexamethasone regimen, Rituximab and sirolimus. Outcomes: The patient was transfusion independent after therapies. Lessons: We report a patient with 4 concomitant hematological disorders: T-LGLL, MGUS, CB-LPD, and PRCA, aiming to represent the clinical and flow cytometry characteristics of these concomitant diseases, analyze the mechanism between diseases, and provide a clinical reference.